Less Survivable Cancers Debate
Full Debate: Read Full DebateDepartment: Department of Health and Social Care
Scott Arthur
Main Page: Scott Arthur (Labour - Edinburgh South West)Department Debates - View all Scott Arthur's debates with the Department of Health and Social Care
(3 days, 5 hours ago)
Westminster HallRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Dr Scott Arthur (Edinburgh South West) (Lab)
It is a pleasure to serve under you today, Mr Efford. I thank the hon. Member for Wokingham (Clive Jones) for securing this debate, a week ahead of Less Survivable Cancers Awareness Week.
The six less survivable cancers—those of the brain, liver, lungs, pancreas, oesophagus and stomach—take 67,000 lives every year. That is equivalent to two people every week in each UK constituency—a non-trivial number. The survival rate at five years is just 16%, so for many people who get a diagnosis of one of these cancers, it must feel like a death sentence.
Too often, people with these cancers are diagnosed late. Only 28% of less survivable cancers are diagnosed at stages 1 and 2, compared with 54% of cancers overall, and too many diagnoses are made in emergency departments, where treatment choices are limited. More broadly, we should never forget that someone who is female or from an ethnic minority is much more likely to be diagnosed with cancer in A&E, which is absolutely shameful.
We know what change would look like. If we could double early diagnosis across those six cancers, we could save an additional 7,500 lives every year. That should be our goal, and that is why I am proud that this Government are focused on prioritising early detection and faster diagnosis. I am pleased to see the Under-Secretary of State for Health and Social Care, my hon. Friend the Member for West Lancashire (Ashley Dalton), here with us today. She is respected and trusted by the wider sector to deliver that agenda as part of the cancer plan, which hopefully we will see next month.
This change can be achieved through investing in research, as we heard from my hon. Friend the Member for Mitcham and Morden (Dame Siobhain McDonagh), as well as supporting the roll-out of innovative tests—such as liquid biopsies and the breath test for pancreatic cancer, which we saw at the UK Labour party conference—and expanding proactive case finding for those most at risk. Centres of excellence, better data and stronger national leadership are also critical.
I speak not just as a participant in today’s debate but as the sponsor of the Rare Cancers Bill, which hon. Members have mentioned; I thank them for their kind comments. The Bill is designed to help address exactly those gaps. I introduced it after my father-in-law Ivor died of glioblastoma, the cancer type that my hon. Friend the Member for Mitcham and Morden has dedicated so much of her life to defeating. My Bill seeks to improve data collection, increase access to clinical trials and strengthen pathways for people with rare and less survivable cancers. The voices of those patients are often not heard. I really hope that in today’s debate, people will feel that they are heard. I look forward to the Minister’s response.